Artificial Intelligence | Machine Learning | Machine Perception Lazarus | AI built for Skin Cancer


Enterprise, Skin Cancer, Images, Doctors, Machine Learning, Healthcare, Oncology, Diagnostics, Deep Learning Cambridge, MA, United States

Lazarus

Artificial Intelligence | Machine Learning | Machine Perception


Lazarus | AI built for Skin Cancer

Lazarus

Skin Cancer, Images, Doctors, Machine Learning, Healthcare, Oncology, Diagnostics, Deep Learning


Cambridge, MA, United States

Lazarus uses patient health data and AI to detect cancer early. The company has clinical decision support systems for skin and cervical cancer, which help improve the diagnostic accuracy of physicians. Lazarus CDS helps clinicians make better decisions when it comes to skin cancer screenings. Lazarus CDS was built with input from dermatologists, patients, and clinical support staff to make sure we have the features that you need most. Not only do our neural networks routinely get dermatologist-level classification accuracy, they also clearly explain every single decision, enabling you, the clinician, to feel truly comfortable with every choice you make. With the presence of human error and a lack of dermoscopy, screening for melanoma over telemedicine platforms is famously difficult. Lazarus CDS bridges the gap by giving you a second opinion to make screening lesions over a photo significantly less risky.

 
 

   Total Funding: $2402000

   Funding Stage: Funded

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 26 to 50

   Founded: 2017

 
 
 
 
Ariel Elizarov


Ariel Elizarov
Founder

Anish Patel


Anish Patel
Chief Technology Officer

 
 

Lazarus is growing. Want to work at Lazarus? Lazarus is hiring. Join team at Lazarus

 
 
appengine.ai

World's Most Promising AI/ML Startups